CARMA-1-PREG

CARMA-1-PREG is investigating factors related to pre-term deliveries among HIV positive women.

Principal Investigator: Dr. Deborah Money

CARMA 7: Bone and Renal Outcomes in HIV-Exposed, Uninfected Infants with Perinatal Exposure to Tenofovir

The purpose of CARMA 7 is to investigate how fetal exposure to the anti-HIV medication Tenofovir may affect the bone and kidney health of infants who are born to HIV+ women.

Principle Investigator: Dr. Ariane Alimenti

Personalized Contraception for Canadians – Decision analytic modelling to support women-centered choices

Personalized Contraception for Canadians- Decision analytic modelling to support women-centered choices Principal Investigator: Dr. Flora Teng Primary Contact: Weihong Chen, Research Coordinator, 604-875-2424 x 4894, Weihong.chen@ubc.ca About the study: This study will develop and pilot test a Canadian woman-centered contraception decision-making mobile application. This app will be “effectiveness-based” and will incorporate factors women consider important when choosing […]

MIST (Mindfulness, Incontinence and Sexual function Treatment) Study Research Proposal for a Pilot Study

MIST (Mindfulness, Incontinence and Sexual function Treatment) Study Research Proposal for a Pilot Study Principal Investigators: Dr. Maryse Larouche/Dr. Geoffrey Cundiff Primary Contact: Nicole Koenig, Research Coordinator, 604-806-9829, nkoenig@providencehealth.bc.ca About the study: This study aims to determine if there is an impact on sexual distress using mindfulness-based sex therapy (MBST) in addition to standard urogynecologic care, in women […]

Mifepristone Implementation Research in Canada

Mifepristone implementation research in Canada – The CART-Mife Study Principal Investigator: Dr. Wendy Norman Primary Contact: Sarah Munro, Post-doctoral Fellow, 604-875-2424 ext 4990, Sarah.Munro@ubc.ca About the study: Mifepristone, approved by Health Canada, will be introduced in 2017. Currently 96% of Canadian abortions are surgical, largely concentrated in the largest cities close to the southern border. Overcoming […]

Canadian Sexual Health Survey Study

Canadian Sexual Health Survey Study Principal Investigators: Dr. Wendy Norman, Dr. Stirling Bryan Primary Contact: Eva McMillan, Research Coordinator, 604-875-2424 x 4871, eva.mcmillan@ubc.ca About the study: This study developed and validated the Canadian Sexual Health Survey (CSHS) that aimed to collect data on sexual and reproductive health among women aged 14-49 years throughout BC. The survey was then […]

Better Contraceptive Choices: Insertion timing and effectiveness of intrauterine and other contraceptive methods post-abortion

Better Contraceptive Choices: Insertion timing and effectiveness of intrauterine and other contraceptive methods post-abortion Principal Investigator: Dr. Wendy Norman Primary Contact: Weihong Chen, Research Coordinator, 604-875-2424 x 4894, Weihong.chen@ubc.ca About the study: This project includes two randomized controlled trials:  1) Immediate vs. delayed insertion of intrauterine contraception after second trimester abortion; and, 2) Is FlexiT non-inferior to […]

Attitudes and intentions to receive medical and surgical abortions among women seeking pregnancy termination

Principal Investigator: Dr. Brian Fitzsimmons Primary Contact: Nicole Prestley, Research Manager, 604-875-2424 ext 4956, Nicole.Prestley@cw.bc.ca  About the study: Health Canada has recently approved Mifegymiso, a medication which is used around the world for medical termination of pregnancy. In order to understand how the use of this medication will impact Canadian women, WHRI is leading a study […]

WHRI Award Winners: UBC Department of OBGYN Academic Day

Congratulations to the WHRI’s Elizabeth McClymont and Dr. Chelsea Elwood for being awarded best Graduate Student and Best Fellow presentations at last Wednesday’s UBC Department of OBGYN Academic Day. Elizabeth McClymont, a Master’s student in Reproductive Sciences working with supervisor Dr. Deborah Money, received the Best Graduate Student award for her presentation, “Two-Year Efficacy of the […]